Background The human papillomavirus (HPV) vaccine offers an opportunity to reduce health inequalities associated with cervical cancer provided the vaccine is delivered equitably at population level.
Introduction
Since 2006, bivalent and quadrivalent HPV vaccines have been licensed globally for females aged between 9 and 26 years. 1 If administered before sexual debut, both vaccines offer protection against HPV 16 and 18 which are responsible for approximately 70% of cases of cervical cancer. 2 The World Health Organization recommends a three-dose immunization schedule for females aged between 9 and 13 years. 3 Socioeconomic disparities of cervical cancer persist throughout countries and populations worldwide; the most disadvantaged groups of women experience an incidence approximately twice that of the least disadvantaged, regardless of the existence of national screening programmes. 4 In the USA, age-adjusted cervical cancer incidence is 2 and 1.5 times as frequent for Hispanic and African American women, respectively, in comparison with non-Hispanic White women. 5 In recent years, many countries have introduced the HPV vaccine into their national immunization programmes. There is the potential to increase health inequalities if uptake is lower amongst already disadvantaged communities. 4, 5 Therefore, the aim of this systematic review and meta-analysis is to summarize evidence on the uptake of HPV vaccination programmes in adolescent young womenby ethnicityand socioeconomic status.
Method Data sources
We followed the PRISMA guidelines throughout the design, conduct and reporting of this systematic review. 6 A comprehensive search strategy was developed using a combination of text words and the following indexing terms (MeSH): 'papillomavirus', 'wart virus', 'vaccination', 'immunization', 'immunization programs', 'wart virus vaccines', 'socioeconomics', 'healthcare disparity', 'minority health', 'minority groups' and 'ethnic groups' (available from authors on request). The following databases were searched from inception to 9 March 2012: Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, Medline, PsycINFO and ISI Web of Science and ISI Proceedings. Abstracts were saved using Endnote X3.
Study selection
Studies were eligible if vaccine uptake in young women aged 418 years was reported by at least one of the following: (i) primary caregiver/household highest educational attainment; (ii) area-level measures of deprivation; (iii) primary caregiver/household annual income; (iv) healthcare insurance coverage status (US-based studies only); (v) ethnicity; (vi) religion, and; (vii) frequency of religious attendance. Studies reporting country of birth as a proxy for ethnicity, or intention to receive the HPV vaccine, were excluded.
Conference abstracts were included if they reported sufficient information related to the variables of interest. Reviews, editorials, dissertations, letters and books were included if they presented original data. Where cohorts were reported in multiple publications, the priority for inclusion was the publication reporting the greatest number of variables of interest. Publications reporting initiation and completion separately were reported together.
Titles and abstracts of all identified studies and relevant full texts were assessed by two independent reviewers (H.F. and K.M-W.). Authors were contacted to provide additional information if data were not reported in a suitable format for data synthesis. If not provided, the study was excluded. No language restrictions were applied.
Quality assessment of the included studies was undertaken to illustrate potential sources of bias using an appraisal tool adapted for use in observational studies 7 by one reviewer (H.F.). Studies were not excluded on this basis in view of the predominantly observational nature of the primary studies.
Data extraction
Information relevant to the study characteristics including delivery site of vaccine, study methodology and study results were extracted by one reviewer (H.F.) and double-checked by another (S.A.).
For ethnicity, data were grouped by the following categories: 'White', 'Black', 'Latina' and 'Asian'. Adjusted and unadjusted ORs and the corresponding 95% CIs pertaining to each category were extracted, taking the White ethnic group as the reference group.
To facilitate comparisons, data relating to the highest and lowest category of primary caregiver/household education, primary caregiver/household income and area-level deprivation were extracted, taking the highest level as the reference category. Household/primary caregiver income and area-level deprivation data were treated separately throughout analyses. For USA-based studies only, healthcare insurance status indicators were grouped as insured and not insured and relevant data extracted. Insured was treated as the reference category. Additional data were extracted by sub-categories to investigate heterogeneity.
Statistical methods
Total heterogeneity between studies independent of number of studies was evaluated using the Q-statistic and the I 2 -statistics. 8 Evidence of heterogeneity was classified as weak, moderate and strong for corresponding I 2 of 25%, 50% and 75%, respectively. Pooled results from a random-effects model were reported if heterogeneity was weak or moderate. If heterogeneity was strong, studies were presented narratively. Final analyses comprized adjusted ORs (aORs) where available, with unadjusted ORs used if not reported.
INEQUALITIES IN THE UPTAKE OF HUMAN PAPILLOMAVIRUS VACCINATION
To identify potential study-level factors contributing to heterogeneity, meta-regression modelling was undertaken. Dummy variables were created for study design, verification of HPV vaccination status, high uptake and adjustment for socioeconomic and other variables of interest. Study year was added to the model as a categorical variable. The natural logarithm OR of each socioeconomic and ethnicity variable was used as the dependent variable and study-level factors as the independent variables.
Results
Of 1093 records initially identified through the database searches, 699 abstracts were reviewed and 123 full-text articles were assessed for eligibility. Full-text studies were excluded for not reporting uptake of HPV vaccination by ethnicity or socioeconomic variable of interest (n ¼ 48), not reporting original data on uptake (n ¼ 28), duplication of study (n ¼ 13), and initiation not reported by the age group of interest (n ¼ 2). A total of 29 publications reporting uptake in 27 studies met the inclusion criteria ( Figure 1 The majority of studies were from the USA (n ¼ 22, 81.5%) with additional studies from Canada (2) and Europe (one each from Belgium, The Netherlands and the UK). Most of the studies were cross-sectional questionnaires (13, 48.1%) or retrospective chart reviews (12, 44.4%). Two were prospective cohort studies. Study participants were sampled from the general population (15, 55.6%), from a healthcare setting (9, 33.3%) or schools (3, 11.1%). The majority of studies were in relation to healthcare based vaccination programmes (24, 88.8%). A wide range of demographic (daughters' age, parental age, primary caregiver education, parental marital status, race/ethnicity, region), socioeconomic (income and healthcare insurance coverage related), behavioural (sexually active), healthcarerelated (healthcare visit type, usual source of care for daughter) and HPV-specific variables were adjusted for in the analyses (Table 1) . Figure 1 Flow diagram of study selection procedure (Figure 2) . Of the eight studies comparing HPV vaccination initiation between White and Latina young women, two studies indicated that young Latina women had a higher odds of initiation 10, 16 , two indicated lower odds of initiation 13, 19 and three were equivocal. 19, 22 In the remaining study the proportion of Latina women was too small to interpret the results with confidence.
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Of the four studies permitting comparison of HPV vaccination initiation between White and Asian young women, one study showed strong evidence that Asian young women were less likely to initiate HPV vaccination, 9 whereas the others showed no evidence of a difference. 11, 16, 17 HPV vaccination initiation by religion and frequency of religious attendance There was no strong evidence that religion and frequency of attendance at a place of worship were related to HPV vaccination initiation. Two studies showed no evidence of differences for HPV vaccination initiation by religious faith. 17, 23 Another reported weak evidence that Catholic religious beliefs were associated with increased initiation. 24 One study reported that more frequent religious service attendance was associated with initiation, 24 whereas another suggested the opposite. 25 
HPV vaccination initiation by income or area-level indicators
There were nine studies 13, 14, 16, [18] [19] [20] [21] 26, 27 that facilitated comparison of HPV vaccination initiation by income indicators for primary caregiver or household, and five studies 11, 21, [28] [29] [30] by area-level deprivation. There was strong evidence of heterogeneity in the analysis comparing area-level deprivation and estimates were not pooled (P < 0.001, I
2 ¼ 97.9). Four non USA-based studies indicated that young women living in the most deprived areas were less likely to initiate HPV vaccination than those living in the least. counter to this. 21 The combined OR showed no strong association between low income and initiation of HPV vaccination (combined OR: 1.16, 95% CI: 1.00-1.34) (Figure 3 ).
HPV vaccination initiation by primary caregiver educational attainment
There were 12 studies 14, [16] [17] [18] 20, 21, 23, [25] [26] [27] 31, 32 that reported data facilitating comparison by primary caregiver educational attainment. The pooled estimates indicate no evidence for difference in HPV vaccination initiation in young women by primary caregiver educational attainment category (combined OR 1.06, 95% CI: 0.92-1.22, P ¼ 0.09, I 2 ¼ 37.3) (Figure 4 ).
HPV vaccination initiation by healthcare insurance coverage
Eight USA-based studies [13] [14] [15] [16] 18, 20, 21, 26 reported initiation by healthcare insurance coverage. The pooled results indicated lower odds of initiating HPV vaccination for young women who had no healthcare insurance coverage in comparison with those who had healthcare insurance coverage (combined OR: 0.56, 95% CI: 0.40-0.78) ( Figure 5 ).
Other sub-analyses
Further ad hoc sub-analyses excluding studies considered to be at high risk of bias resulted only in minor changes to combined effect sizes and heterogeneity by ethnic and socioeconomic variables of interest. There were insufficient studies to permit sub-analysis either by vaccination programme delivery setting or countries with publicly funded HPV vaccination programmes.
Investigating sources of heterogeneity
To investigate sources of heterogeneity, meta-regression analysis was undertaken. Adjustment for the study-level variables 'self-report measurement of HPV status' and 'adjustment for primary caregiver education status' reduced heterogeneity for the analysis comparing initiation by White and Black ethnic group (I 2 ¼ 45.0%). Reductions in heterogeneity were not observed across other analyses.
HPV vaccination completion by ethnicity
Completion of the HPV vaccine course by ethnicity was reported by six studies. 10, 15, 21, [33] [34] [35] Four studies 10, [33] [34] [35] provided evidence that young Black women were less likely to complete the HPV vaccine course, whereas two were equivocal. 15, 21 Two studies provided evidence that Latina young women were less likely to complete HPV vaccination series than White young women, whereas results from four other studies showed no difference. 21, [34] [35] [36] Two studies reported that Asian young women were more likely to complete HPV vaccination series than White young women. 
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HPV vaccination completion by income or area-level indicators Few studies reported completion by income; one study presented strong evidence to support that young women belonging to lower family income categories are less likely to complete HPV vaccination. 36 Similarly for area-level deprivation indicators: one study offered evidence to suggest that young women living in the most deprived neighbourhood quintile were less likely to complete the vaccine series.
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HPV vaccination completion by primary caregiver educational attainment Few studies reported completion by primary caregiver education; one study indicated young women belonging to families with lower education attainment are less likely to complete.
36
HPV vaccination completion by healthcare insurance coverage In one study, young women with private insurance were more likely to have completed the vaccination series that those with public insurance. 33 
Discussion
Key findings This systematic review indicates that Black young women are less likely to initiate HPV vaccination in comparison with White young women (combined OR: 0.89, 95% CI: 0.82-0.97). In the USA, young women without healthcare insurance coverage were less likely to initiate HPV vaccination (combined OR: 0.56, 95% CI: 0.40-0.78). However, there was no strong evidence for differences of initiation by family income or primary caregiver educational achievement.
Strengths and limitations
We followed a systematic and comprehensive process including: a search strategy applied to multiple databases to uncover all relevant studies; no restrictions on the basis of publication date or language; titles, abstracts and full-text studies independently reviewed by two of the authors; and study authors contacted to provide additional information to minimize study selection bias. We were also able to incorporate some meta-analyses and investigate sources of heterogeneity through sub-analyses and meta-regression techniques.
* Study reported adjusted odds ratios
Overall (I 2 = 37.3%, P = 0.093)
Yeganeh N et al. Figure 4 Odds ratios of HPV vaccination initiation by lowest primary caregiver education category in comparison with highest
Nonetheless there are several potential limitations. There was considerable heterogeneity between studies including differences in study design, reporting of socioeconomic and ethnicity variables, type and number of confounders, and definition of reference groups. This limited the application of meta-analysis. Examining possible causes of heterogeneity by metaregression yielded little additional insight into sources of heterogeneity. Potential explanations for residual heterogeneity include: variation in the populations from which study samples were drawn; modality of healthcare insurance coverage scheme, and; vaccination delivery setting.
The measures of ethnicity as used in this study are crude and do not reflect different cultural beliefs and norms within ethnic sub-populations. Few studies reported other ethnicity-related variables, such as religion, which could conceivably influence HPV vaccination uptake.
Recall and response bias may be present in studies using self-report measures of HPV vaccination status. 13, 14, [17] [18] [19] 21, [24] [25] [26] 31, 32 Both, unadjusted and aORs have been presented because of inconsistency of reporting. Examining HPV vaccination uptake by ethnicity, without accounting for socioeconomic circumstances, does not accurately portray the impact of cultural differences. Adjustment for these confounders in the studies included in this review generally resulted in ORs deviating towards the null and results may be overestimated. Studies reporting both socioeconomic position and ethnicity allowing adjustment for confounding are required.
The majority of studies included in the review are from the USA where insurance is the predominant model of healthcare and the HPV vaccine is usually delivered in the primary care setting. The results may not be generalizable to different healthcare systems offering universal health care, population types or different vaccination delivery methods, such as schoolbased programmes delivered free at the point of care, frequently implemented in other countries. All of the studies meeting the inclusion criteria were from higher resource countries. No studies were retrieved from the African and Asian continents, where the majority of cases of cervical cancer occur, 37 despite the availability of the HPV vaccine in a number of countries.
Finally, completion (rather than initiation) of the HPV vaccination series was reported too infrequently to permit meta-analyses.
Findings in relation to other studies A systematic review reporting hypothetical acceptance suggested there would be no difference in acceptability of HPV vaccination by ethnicity, but lower education and higher income was associated with higher acceptability. 38 Our meta-analyses indicate that high acceptability has not been translated into HPV vaccination uptake in Black young women, which is of concern given the higher incidence of cervical cancer in this population group. 5 The factors affecting HPV vaccination uptake in Black young women are not yet fully understood. They may relate to lower socioeconomic status experienced by many ethnic groups, or cultural differences in relation to attitudes to preventive health care. Qualitative studies to elicit cultural or religious beliefs related to HPV vaccination initiation may help explain some differences. In addition, targeted media publicity campaigns and physician recommendation may be helpful to promote vaccination uptake. We found that young women without healthcare insurance coverage were less likely to initiate HPV vaccination. This is an important finding as lower uptake could exasperate existing inequalities in cervical cancer incidence 4 and screening attendance 39 in disadvantaged populations. Cost and access to healthcare are perceived as barriers to vaccination by young women without healthcare insurance coverage, despite free availability through the Vaccines for Children programme in the USA. 40 Informing uninsured young women and their primary caregivers who are eligible about available resources may help alleviate some of the perceived barriers to vaccination.
A previous systematic review reported that higher HPV vaccine initiation was associated with having numerous factors, including health insurance, older age, receipt of childhood vaccines and positive vaccine attitudes. 41 The authors also suggested that African American young women are less likely to initiate, although the results from individual studies were not pooled in a metaanalysis. The current study supports and strengthens this argument by focusing on ethnic and socioeconomic differences in uptake, reporting the results from approximately double the number of studies, and including some meta-analysis.
The highest uptake rates reported in this study were achieved through school-based vaccination programmes 11, 17, 30 which have been shown to be acceptable and convenient to parents/carers. 42, 43 The observed lower uptake of the HPV vaccine in the general practice setting may be as a result of a reliance on opportunistic strategies for vaccine delivery. For a population who typically utilize healthcare infrequently, this approach may not be appropriate if high coverage is to be achieved. This study demonstrated inequalities in uptake in general practice-based setting, even in a setting with universal healthcare. 29 School-based programmes could be advantageous in overcoming practical barriers to healthcare access in the primary care setting, such as transport issues or appointment restrictions, 44, 45 and promoting more equitable coverage of the HPV vaccine. More detailed understanding of the contextual factors contributing to differences of uptake by vaccination delivery setting would be beneficial to inform future HPV vaccination programmes or other health initiatives.
Conclusions
We found strong evidence for differences in HPV vaccination initiation by ethnicity and healthcare coverage, but not for parental education or family income. Future population-based studies reporting initiation and completion of the HPV vaccination series are required to establish whether the patterns of initiation reported here are replicated in healthcare settings outside the USA. Further research should identify barriers and develop interventions to improve uptake in specific populations identified with lower uptake.
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